1. Home
  2. UNCY vs NIPG Comparison

UNCY vs NIPG Comparison

Compare UNCY & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • NIPG
  • Stock Information
  • Founded
  • UNCY 2016
  • NIPG 2014
  • Country
  • UNCY United States
  • NIPG Sweden
  • Employees
  • UNCY N/A
  • NIPG N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • NIPG
  • Sector
  • UNCY Health Care
  • NIPG
  • Exchange
  • UNCY Nasdaq
  • NIPG NYSE
  • Market Cap
  • UNCY 91.0M
  • NIPG 96.4M
  • IPO Year
  • UNCY 2021
  • NIPG 2024
  • Fundamental
  • Price
  • UNCY $4.55
  • NIPG $2.14
  • Analyst Decision
  • UNCY Strong Buy
  • NIPG Strong Buy
  • Analyst Count
  • UNCY 4
  • NIPG 1
  • Target Price
  • UNCY $63.75
  • NIPG $6.00
  • AVG Volume (30 Days)
  • UNCY 1.5M
  • NIPG 399.1K
  • Earning Date
  • UNCY 08-13-2025
  • NIPG 04-30-2025
  • Dividend Yield
  • UNCY N/A
  • NIPG N/A
  • EPS Growth
  • UNCY N/A
  • NIPG N/A
  • EPS
  • UNCY N/A
  • NIPG N/A
  • Revenue
  • UNCY N/A
  • NIPG $85,266,306.00
  • Revenue This Year
  • UNCY N/A
  • NIPG $11.25
  • Revenue Next Year
  • UNCY $1,458.53
  • NIPG $33.33
  • P/E Ratio
  • UNCY N/A
  • NIPG N/A
  • Revenue Growth
  • UNCY N/A
  • NIPG 1.91
  • 52 Week Low
  • UNCY $2.02
  • NIPG $0.99
  • 52 Week High
  • UNCY $11.00
  • NIPG $17.76
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 39.53
  • NIPG N/A
  • Support Level
  • UNCY $4.76
  • NIPG N/A
  • Resistance Level
  • UNCY $7.15
  • NIPG N/A
  • Average True Range (ATR)
  • UNCY 0.97
  • NIPG 0.00
  • MACD
  • UNCY -0.28
  • NIPG 0.00
  • Stochastic Oscillator
  • UNCY 7.37
  • NIPG 0.00

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS

NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand influence globally, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.

Share on Social Networks: